A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
January 31, 2016
Primary Completion Date
September 30, 2016
Study Completion Date
December 31, 2016
Conditions
AgingMitochondrial DysfunctionMuscle Function
Interventions
DIETARY_SUPPLEMENT
Mitopure
Trial Locations (1)
38610
Eurofins Optimed, Gières
All Listed Sponsors
collaborator
Eurofins Optimed
INDUSTRY
lead
Amazentis SA
INDUSTRY
NCT02655393 - A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects | Biotech Hunter | Biotech Hunter